The LuxR family regulator SAV111 enhances avermectin production by binding to aveA1 gene promoter in Streptomyces avermitilis
Archives of Microbiology · 2026
DOI: 10.1007/s00203-025-04576-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Shuai Luo und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Engineering, Beijing Polytechnic University, Beijing, 100176, China. Hauptthemen laut MEDLINE: Streptomyces, Ivermectin, Promoter Regions, Genetic, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Polytechnic project.
Abstract (Originalsprache)
Avermectins, macrocyclic lactones produced by Streptomyces avermitilis, serve as essential therapeutic and agrochemical agents. LuxR-type transcriptional regulators are multifunctional proteins known to orchestrate antibiotic biosynthesis alongside virulence modulation, biofilm dynamics, and host immune interactions. However, no prior studies have characterized LuxR-family proteins as direct regulators of avermectin biosynthesis. This study delineates the mechanism through which SAV111, a LuxR-family transcriptional activator, enhances avermectin biosynthesis. Batch fermentation of the SAV111-overexpressing strain demonstrated dual functionality: (1) significant upregulation of avermectin titers and (2) accelerated hyphal growth kinetics. Developmental profiling revealed precocious morphological differentiation in the overexpression strain compared to wild-type controls. Electrophoretic mobility shift assays confirmed direct binding of SAV111 to the aveA1 promoter, encoding the synthase catalytic subunit within the pathway of avermectin biosynthetic. Transcriptional activation of aveA1 represents the primary mechanism underlying SAV111-mediated avermectin overproduction. These findings advance the understanding of LuxR-family regulatory networks in secondary metabolism and establish a molecular framework for engineering hyperproductive S. avermitilis strains.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Engineering, Beijing Polytechnic University, Beijing, 100176, China.
- Key Laboratory of Urban Agriculture (North China), Ministry of Agriculture and Rural Affairs, Beijing, 100097, China.
- Fisheries Sciences Institute, Beijing Academy of Agriculture and Forestry Sciences, Beijing, 100068, China.
- Department of English, Beijing Health Vocational College, Beijing, 102402, China. 15301029626@163.com.
- The Sixth Medical Center, PLA General Hospital, Beijing, 100048, China. yangming301@163.com.
Förderung
- Beijing Polytechnic project
Zitieren
APA
Luo, S., Zhu, J., Zhang, H., Wen, Y., Wang, X., Chen, L., Deng, L., & Yang, M. (2026). The LuxR family regulator SAV111 enhances avermectin production by binding to aveA1 gene promoter in Streptomyces avermitilis. Archives of Microbiology. https://doi.org/10.1007/s00203-025-04576-w
Vancouver
Luo S, Zhu J, Zhang H, Wen Y, Wang X, Chen L, et al. The LuxR family regulator SAV111 enhances avermectin production by binding to aveA1 gene promoter in Streptomyces avermitilis. Archives of Microbiology. 2026. doi:10.1007/s00203-025-04576-w
BibTeX
@article{Luo2026,
author = {Luo, Shuai and Zhu, Jianya and Zhang, Hucheng and Wen, Yaqin and Wang, Xiaojie and Chen, Liang and Deng, Lina and Yang, Ming},
title = {The LuxR family regulator SAV111 enhances avermectin production by binding to aveA1 gene promoter in Streptomyces avermitilis},
journal = {Archives of Microbiology},
year = {2026},
doi = {10.1007/s00203-025-04576-w}
}
EUVIMED